BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11490570)

  • 1. Catabolism of skeletal muscle proteins and its reversal in cancer cachexia.
    Tisdale MJ
    Nestle Nutr Workshop Ser Clin Perform Programme; 2000; 4():135-43; discussion 144-6. PubMed ID: 11490570
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of skeletal muscle in cancer: biochemical mechanisms.
    Tisdale MJ
    Front Biosci; 2001 Feb; 6():D164-74. PubMed ID: 11171557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathways leading to cancer cachexia.
    Tisdale MJ
    Physiology (Bethesda); 2005 Oct; 20():340-8. PubMed ID: 16174873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedicine. Protein loss in cancer cachexia.
    Tisdale MJ
    Science; 2000 Sep; 289(5488):2293-4. PubMed ID: 11041796
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia.
    Baracos VE
    Nutrition; 2000 Oct; 16(10):1015-8. PubMed ID: 11054610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional/metabolic response in older cancer patients.
    Horstman AM; Sheffield-Moore M
    Nutrition; 2015 Apr; 31(4):605-7. PubMed ID: 25770327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer anorexia and cachexia.
    Tisdale MJ
    Nutrition; 2001 May; 17(5):438-42. PubMed ID: 11377146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cachexia in cancer patients.
    Tisdale MJ
    Nat Rev Cancer; 2002 Nov; 2(11):862-71. PubMed ID: 12415256
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.
    Mirza KA; Pereira SL; Voss AC; Tisdale MJ
    Nutrition; 2014; 30(7-8):807-13. PubMed ID: 24984997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cachexia: from experimental models to patient management.
    Costelli P; Baccino FM
    Curr Opin Clin Nutr Metab Care; 2000 May; 3(3):177-81. PubMed ID: 10871232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
    Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
    Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 'cancer cachectic factor'.
    Tisdale MJ
    Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia.
    Melstrom LG; Melstrom KA; Ding XZ; Adrian TE
    Histol Histopathol; 2007 Jul; 22(7):805-14. PubMed ID: 17455154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
    Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
    Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing Metabolic Dysregulation in Muscle During Cachexia.
    Hsu MY; Porporato PE; Wyart E
    Methods Mol Biol; 2019; 1928():337-352. PubMed ID: 30725463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding cachexia and excessive weight loss in cancer.
    Hemming L; Maher D
    Br J Community Nurs; 2005 Nov; 10(11):492-5. PubMed ID: 16301922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New mediators in cancer cachexia.
    Argilés JM; López-Soriano FJ
    Nestle Nutr Workshop Ser Clin Perform Programme; 2000; 4():147-62; discussion 163-5. PubMed ID: 11490571
    [No Abstract]   [Full Text] [Related]  

  • 18. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.
    Attaix D; Combaret L; Tilignac T; Taillandier D
    Mol Biol Rep; 1999 Apr; 26(1-2):77-82. PubMed ID: 10363651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.
    Miyamoto Y; Hanna DL; Zhang W; Baba H; Lenz HJ
    Clin Cancer Res; 2016 Aug; 22(16):3999-4004. PubMed ID: 27340276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling.
    Pettersen K; Andersen S; Degen S; Tadini V; Grosjean J; Hatakeyama S; Tesfahun AN; Moestue S; Kim J; Nonstad U; Romundstad PR; Skorpen F; Sørhaug S; Amundsen T; Grønberg BH; Strasser F; Stephens N; Hoem D; Molven A; Kaasa S; Fearon K; Jacobi C; Bjørkøy G
    Sci Rep; 2017 May; 7(1):2046. PubMed ID: 28515477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.